IL51481A - Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation - Google Patents

Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation

Info

Publication number
IL51481A
IL51481A IL51481A IL5148177A IL51481A IL 51481 A IL51481 A IL 51481A IL 51481 A IL51481 A IL 51481A IL 5148177 A IL5148177 A IL 5148177A IL 51481 A IL51481 A IL 51481A
Authority
IL
Israel
Prior art keywords
furoyl
piperazin
crystalline
amino
preparation
Prior art date
Application number
IL51481A
Other languages
English (en)
Other versions
IL51481A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL51481A0 publication Critical patent/IL51481A0/xx
Publication of IL51481A publication Critical patent/IL51481A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL51481A 1976-03-01 1977-02-17 Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation IL51481A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (2)

Publication Number Publication Date
IL51481A0 IL51481A0 (en) 1977-04-29
IL51481A true IL51481A (en) 1980-09-16

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51481A IL51481A (en) 1976-03-01 1977-02-17 Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation

Country Status (32)

Country Link
US (1) US4092315A (sv)
JP (1) JPS604188B2 (sv)
AR (1) AR210937A1 (sv)
AU (1) AU506937B2 (sv)
BE (1) BE851878A (sv)
BG (1) BG29724A3 (sv)
CA (1) CA1068269A (sv)
CH (1) CH618436A5 (sv)
CS (1) CS191332B2 (sv)
DD (1) DD129652A5 (sv)
DE (1) DE2708192C3 (sv)
DK (1) DK145858C (sv)
ES (1) ES8707447A1 (sv)
FI (1) FI62082C (sv)
FR (1) FR2372828A1 (sv)
GB (1) GB1538713A (sv)
HK (1) HK30881A (sv)
HU (1) HU173641B (sv)
IE (1) IE44522B1 (sv)
IL (1) IL51481A (sv)
LU (1) LU76868A1 (sv)
MY (1) MY8100271A (sv)
NL (1) NL169591C (sv)
NO (1) NO146499C (sv)
NZ (1) NZ183450A (sv)
PL (1) PL105559B1 (sv)
PT (1) PT66227B (sv)
RO (1) RO73095A (sv)
SE (1) SE423234B (sv)
SU (1) SU644387A3 (sv)
YU (1) YU41294B (sv)
ZA (1) ZA77918B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (sv) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Förfarande för framställning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
EP0849266B8 (de) * 1996-12-20 2007-10-03 Heumann PCS GmbH Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
US9976252B2 (en) 2014-07-21 2018-05-22 Keir Manufacturing, Inc. Aerodynamic flyer bow

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents

Also Published As

Publication number Publication date
DE2708192A1 (de) 1977-09-08
FR2372828A1 (fr) 1978-06-30
DD129652A5 (de) 1978-02-01
IE44522L (en) 1977-09-01
DE2708192B2 (de) 1979-08-02
SU644387A3 (ru) 1979-01-25
CH618436A5 (sv) 1980-07-31
PT66227B (en) 1978-07-14
RO73095A (ro) 1981-06-26
DK145858B (da) 1983-03-21
GB1538713A (en) 1979-01-24
NO770674L (no) 1977-09-02
CS191332B2 (en) 1979-06-29
LU76868A1 (sv) 1977-09-21
YU49977A (en) 1983-12-31
FI770634A (sv) 1977-09-02
US4092315A (en) 1978-05-30
IL51481A0 (en) 1977-04-29
PL196354A1 (pl) 1978-02-27
NZ183450A (en) 1979-03-16
JPS52105206A (en) 1977-09-03
BG29724A3 (en) 1981-01-15
CA1068269A (en) 1979-12-18
NL169591B (nl) 1982-03-01
AU2244377A (en) 1978-11-23
AR210937A1 (es) 1977-09-30
NO146499B (no) 1982-07-05
DE2708192C3 (de) 1980-05-08
FR2372828B1 (sv) 1980-02-01
FI62082B (fi) 1982-07-30
AU506937B2 (en) 1980-01-31
PT66227A (en) 1977-03-01
NL7702123A (nl) 1977-09-05
DK145858C (da) 1983-09-12
MY8100271A (en) 1981-12-31
JPS604188B2 (ja) 1985-02-01
SE7701624L (sv) 1977-09-02
NL169591C (nl) 1982-08-02
YU41294B (en) 1987-02-28
SE423234B (sv) 1982-04-26
BE851878A (fr) 1977-08-29
ES8707447A1 (es) 1987-08-16
DK86877A (da) 1977-09-02
FI62082C (fi) 1982-11-10
PL105559B1 (pl) 1979-10-31
HK30881A (en) 1981-07-10
NO146499C (no) 1982-10-13
ZA77918B (en) 1977-12-28
ES545368A0 (es) 1978-06-01
IE44522B1 (en) 1981-12-30
HU173641B (en) 1979-07-28

Similar Documents

Publication Publication Date Title
IL51481A (en) Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation
HK42781A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclocarbonyl)piperozin-1-yl)quinazolines
NL7803036A (nl) 4-(5-fluormethyl-2-pyridyloxy)fenoxyalkaan- carbonzuren en derivaten daarvan.
NL7805647A (nl) Mevalonolactonderivaten, hun gebruik en bereiding.
BR7606291A (pt) Cavalete dobravel e elevacionalmente ajustavel,movel
IL52257A (en) 4-(3,4-dihydroxy-epoxy-5-hydroxy-methylhexyl-tetrahydropyran)-2-yl-3-methylbut-2e-enoic acid and its preparation
NO771168L (no) Piperazin- og piperidinderivater.
PH22196A (en) Novel 4-(cyclic imido-substituted)-6,7-dimethoxy quinazoline derivatives
NL7808319A (nl) 2-pyridyl- en 2-pyrimidylderivaten.
MY8200110A (en) 4-amino-6,7-dimethoxy-2-[4-(heterocy-clocarbonyl)piperazin-1-yl]quinazolines
PH13966A (en) Piperazinyl quinazoline derivatives as antihypertensives
FI790320A (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
NL7803882A (nl) 3-(1-piperazinyl)-1.2.4-benzotriazinen en n-oxiden.
PH16833A (en) 9-hydroxyhexyhydrobenzo-(c)-quinoline,their compositions and use
NL7804361A (nl) Leucinerijk 3,1-s-alpha2-glycoproteine, zijn berei- ding en toepassing.
IL52394A0 (en) The preparation of 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline
HK33582A (en) Substituted aminoakyl phthalazinones and quinazolinones
FI763613A (fi) Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
NL7700520A (nl) Piperidinehydroxyamiden, hun bereiding en toepassing.
BE871821A (fr) Derives de quinazoline, leur preparation et leur utilisation
PH15619A (en) 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
DK558377A (da) Mellemprodukt ved fremstillingen af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-piperazinyl) quinazolin med blodtrykssaenkende virkning
DK176478A (da) Quinazolinonoxider deres fremstilling og anvendelse
NZ193511A (en) 4-amino-6,7-di(lower alkoxy)-2-(4-substituted piperazin-1-yl) quinazolines
DK146510C (da) 2-(4-(2-furoyl)piperazin-1-yl)-4-phthalimido-6,7-dimethoxyquinazolin til anvendelse som mellemprodukt ved fremstilling af 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazolin